Detalles de la búsqueda
1.
Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy.
Int J Gynecol Cancer
; 28(6): 1153-1161, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29794499
2.
Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.
Support Care Cancer
; 25(5): 1661-1671, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28108820
3.
Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy.
Support Care Cancer
; 19(12): 2063-6, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976035
4.
Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients.
J Geriatr Oncol
; 8(1): 56-63, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27889278
5.
Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
Curr Opin Support Palliat Care
; 10(2): 180-8, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028050
6.
A Multifaceted Approach to Improve the Availability and Accessibility of Opioids for the Treatment of Cancer Pain in Serbia: Results From the International Pain Policy Fellowship (2006-2012) and Recommendations for Action.
J Pain Symptom Manage
; 52(2): 272-83, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26988849
7.
Severe skin toxicity observed with the combination of capecitabine and weekly paclitaxel in metastatic breast cancer patients.
Support Care Cancer
; 16(12): 1415-8, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18773227
Resultados
1 -
7
de 7
1
Próxima >
>>